Fishers, IN, United States of America

Edward O Ganser

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edward O Ganser: Innovator in Biochemical Reagents

Introduction

Edward O Ganser is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of biochemical reagents, particularly in the measurement of analytes in biological fluids. His work has implications for various medical and scientific applications.

Latest Patents

Edward O Ganser holds a patent for a stable aqueous reagent containing NAD. This reagent is particularly useful in the measurement of ethanol and lactate in biological fluids. The patent describes a reagent that includes alcohol dehydrogenase, pyrazole, NAD, SUTTOCIDE A, and an aliphatic, zwitterionic buffer with a secondary or tertiary amine group. Preferred buffers mentioned in the patent include TAPSO, AMPSO, POPSO, TAPS, and DIPSO. This innovation enhances the accuracy and reliability of alcohol and lactate determinations in clinical settings.

Career Highlights

Edward O Ganser is associated with Boehringer Mannheim GmbH, where he has contributed to the development of advanced biochemical reagents. His expertise in this area has positioned him as a valuable asset to the company and the scientific community.

Collaborations

Some of his notable coworkers include Catherine J Hurt and Allen R Dorn. Their collaborative efforts have likely contributed to the advancements in the field of biochemical analysis.

Conclusion

Edward O Ganser's innovative work in developing stable aqueous reagents has made a significant impact on the measurement of important analytes in biological fluids. His contributions continue to influence the fields of biochemistry and clinical diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…